Pharmaceuticals

Wed, 09/01/2010 - 17:44

Wanbang Bio clinches SFDA marketing approval for pemetrexed disodium

Shanghai. September 1. INTERFAX-CHINA - Shanghai Chemo Wanbang Biopharma Co. Ltd. has obtained marketing approval from the State Food and Drug Administration (SFDA) for pemetrexed disodium injection, its parent company, Shanghai Fosun Pharmaceutical Group Co. Ltd., announced Sept. 1.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW